ArisGlobal was acquired by Dassault Systèmes
In July, Nordic Capital sold its drug-safety firm ArisGlobal for $2B to Dassault Systèmes, seeking to bolster its AI offering and expand its footprint across pharmaceutical development and compliance workflows.